Elias Laurin Meyer

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Top Venues

Clinical pharmacology and therapeutics

Pharmaceutical statistics

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Quynh Lan Nguyen, Katharina Hees, Sabina Hernandez Penna, Franz Koenig, Martin Posch, Marta Bofill Roig, Elias Laurin Meyer, Michaela Maria Freitag, Tom Parke, Maximilian Otte, Hans Peter Dauben, Tobias Mielke, Cecile Spiertz, Peter Mesenbrink, Madhavi Gidh-Jain, Suzanne Pierre, Salvatore Morello, Benjamin Hofner
Regulatory Issues of Platform Trials: Learnings from EU-PEARL. Clinical pharmacology and therapeutics 116 (1) (2024)
Quynh Lan Nguyen, Katharina Hees, Sabina Hernandez Penna, Franz Koenig, Martin Posch, Marta Bofill Roig, Elias Laurin Meyer, Michaela Maria Freitag, Tom Parke, Maximilian Otte, Hans Peter Dauben, Tobias Mielke, Cecile Spiertz, Peter Mesenbrink, Madhavi Gidh-Jain, Suzanne Pierre, Salvatore Morello, Benjamin Hofner
Regulatory Issues of Platform Trials: Learnings from EU-PEARL. Clinical pharmacology and therapeutics (2024)
Elias Laurin Meyer, Peter Mesenbrink, Nicholas A Di Prospero, Juan M Pericàs, Ekkehard Glimm, Vlad Ratziu, Elena Sena, Franz Koenig, null null
Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpoints. PloS one 18 (3) (2023)
Elias Laurin Meyer, Peter Mesenbrink, Nicholas A Di Prospero, Juan M Pericàs, Ekkehard Glimm, Vlad Ratziu, Elena Sena, Franz Koenig, null null
Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpoints. PloS one 18 (3) (2023)
Elias Laurin Meyer, Peter Mesenbrink, Nicholas A Di Prospero, Juan M Pericàs, Ekkehard Glimm, Vlad Ratziu, Elena Sena, Franz Koenig, null null
Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpoints. PloS one 18 (3) (2023)
Elias Laurin Meyer, Peter Mesenbrink, Nicholas A Di Prospero, Juan M Pericàs, Ekkehard Glimm, Vlad Ratziu, Elena Sena, Franz Koenig, null null
Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpoints. PloS one 18 (3) (2023)
Georg Semmler, Bernhard Scheiner, Lorenz Balcar, Rafael Paternostro, Benedikt Simbrunner, Matthias Pinter, Michael Trauner, Marta Bofill Roig, Elias Laurin Meyer, Benedikt Silvester Hofer, Mattias Mandorfer, David James Pinato, Christian Zauner, Thomas Reiberger, Georg-Christian Funk
Disturbances in sodium and chloride homeostasis predict outcome in stable and critically ill patients with cirrhosis. Alimentary pharmacology & therapeutics (2023)
Elias Laurin Meyer, Peter Mesenbrink, Nicholas A Di Prospero, Juan M Pericàs, Ekkehard Glimm, Vlad Ratziu, Elena Sena, Franz Koenig, null null
Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpoints. PloS one 18 (3) (2023)
Elias Laurin Meyer, Peter Mesenbrink, Cornelia Dunger-Baldauf, Ekkehard Glimm, Yuhan Li, Franz Koenig, null null
Decision rules for identifying combination therapies in open-entry, randomized controlled platform trials. Pharmaceutical statistics 21 (3) (2022)